Diligence memo · auto-generated · as of July 2, 2026
Eleison Pharmaceuticals Inc
Eleison Pharmaceuticals Inc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Eleison Pharmaceuticals Inc operates in Pharmaceuticals, based in PRINCETON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Eleison Pharmaceuticals Inc has raised $980K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $980K on 2022-04-28.
Most recent recorded round closed around 2022-04-28.
Valuation (modeled)modeled
Provath models Eleison Pharmaceuticals Inc at approximately $16M (range $549K–$104M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 6.25× the median modeled value of Pre-Seed Pharmaceuticals companies in 2022–2024 (38 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 4.2 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 18% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 24% of those peers.
Closest niche peers: Telomir Pharmaceuticals, Inc., Drusolv Therapeutics, Inc., TF Tech Ventures, Inc., Thyron Pharmaceuticals, Inc., Gelesis Holdings, Inc..
Peoplefiled
9 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.